RNA transcription and uterine growth: differential effects of estradiol, estriol, and nafoxidine on chromatin RNA initiation sites.
D000818:Animals; D002843:Chromatin / Q000187:drug effects / Q000378:metabolism*; D012321:DNA-Directed RNA Polymerases / Q000378:metabolism; D004926:Escherichia coli / Q000201:enzymology; D004958:Estradiol / Q000494:pharmacology*; D004964:Estriol / Q000494:pharmacology*; D005260:Female; D007700:Kinetics; D009256:Nafoxidine / Q000494:pharmacology*; D011759:Pyrrolidines / Q000494:pharmacology*; D051381:Rats; D012293:Rifampin / Q000494:pharmacology; D014158:Transcription, Genetic / Q000187:drug effects*; D014599:Uterus / Q000187:drug effects / Q000378:metabolism*
D002843:Chromatin; D011759:Pyrrolidines; D009256:Nafoxidine; D004958:Estradiol; D012321:DNA-Directed RNA Polymerases; D004964:Estriol; D012293:Rifampin